StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
167
This month
8
This week
1
This year
22
Yesterday
1
Publishing Date
2023 - 12 - 12
2
2023 - 11 - 28
2
2023 - 09 - 22
2
2023 - 08 - 10
3
2023 - 07 - 21
2
2023 - 06 - 23
3
2023 - 05 - 16
2
2023 - 03 - 29
2
2023 - 01 - 24
9
2023 - 01 - 19
2
2022 - 02 - 28
1
2022 - 02 - 22
1
2022 - 02 - 18
1
2022 - 02 - 15
1
2022 - 02 - 09
1
2022 - 01 - 14
2
2021 - 11 - 17
1
2021 - 11 - 11
1
2021 - 11 - 09
2
2021 - 10 - 29
1
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 25
2
2021 - 10 - 20
1
2021 - 10 - 19
1
2021 - 10 - 15
3
2021 - 10 - 14
2
2021 - 10 - 07
1
2021 - 10 - 04
1
2021 - 09 - 21
1
2021 - 09 - 17
1
2021 - 09 - 16
2
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 09 - 01
1
2021 - 08 - 31
1
2021 - 08 - 25
2
2021 - 08 - 24
1
2021 - 08 - 19
1
2021 - 08 - 17
2
2021 - 08 - 05
2
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 30
2
2021 - 07 - 26
1
2021 - 07 - 23
1
2021 - 07 - 19
1
2021 - 07 - 02
1
2021 - 06 - 23
2
2021 - 06 - 15
1
2021 - 06 - 09
1
2021 - 05 - 21
1
2021 - 05 - 19
2
2021 - 05 - 12
1
2021 - 04 - 20
2
2021 - 04 - 12
1
2021 - 04 - 06
1
2021 - 03 - 19
2
2021 - 03 - 16
2
2021 - 03 - 04
1
Sector
Commercial services
3
Consumer non-durables
4
Consumer services
2
Distribution services
1
Electronic technology
3
Finance
4
Health services
2
Health technology
167
Information
8
Manufacturing
7
N/a
10
Non-energy minerals
1
Process industries
5
Producer manufacturing
4
Professional, scientific, and technical services
1
Retail trade
1
Technology services
7
Tags
Aaic
2
Acquisition
3
Alliances
2
Antibody
2
Biopharma
4
Biotech
2
Biotech-bay
2
Biotech-beach
2
Blood
3
Bone
2
Cancer
11
Care
2
Cell
8
Ces
2
Collaboration
2
Commercialization
2
Companies
3
Conference
4
Covid
6
Covid-19
7
Device
2
Disease
4
Drug
11
Earnings
2
Endoscopy
2
Expected
3
Eye
2
Fda
5
Financial
5
Financial results
2
Global
22
Grant
2
Growing
2
Growth
23
Health
2
Innovation
2
Layoffs
3
Lung
3
Macular
2
Market
44
Merge
3
N/a
131
News
4
People
3
Pharm-country
3
Positive
4
Reach
4
Regulatory
3
Report
16
Research
3
Results
10
Sales
4
Set
3
Study
8
Technology
3
Therapeutics
5
Therapy
4
Treatment
7
Vaccine
7
Year
3
Entities
3m company
2
Abbott laboratories
10
Abbvie inc.
6
Alphabet inc.
3
Amarin corporation plc
3
Amgen inc.
10
Applied genetic technologies corporation
3
Applife digital solutions inc
8
Aptargroup, inc.
2
Arcturus therapeutics holdings inc.
3
Astellas pharma inc
3
Astrazeneca plc
5
Athena consumer acquisition corp.
5
Bausch health companies inc.
5
Baxter international inc.
3
Becton, dickinson and company
4
Boston scientific corporation
3
Bristol-myers squibb company
5
Colgate-palmolive company
2
Danaher corporation
2
Eli lilly and company
9
Emergent biosolutions, inc.
2
Epizyme, inc.
2
Galapagos nv
2
Genmab a/s
2
Gilead sciences, inc.
2
Glaxosmithkline plc
14
I-mab
3
Incyte corporation
4
International business machines corporation
2
Ionis pharmaceuticals, inc.
2
Iovance biotherapeutics, inc.
2
Johnson & johnson
167
M3-brigade acquisition iii corp.
8
Medtronic plc
7
Microsoft corporation
2
Morphosys ag
4
Nektar therapeutics
3
Novartis ag
15
Novo nordisk a/s
3
Oncocyte corporation
3
Perrigo company
2
Pfizer, inc.
4
Precision biosciences, inc.
2
Ptc therapeutics, inc.
3
Rallybio corp
4
Revolution medicines, inc.
2
Royalty pharma plc
2
Sanofi
23
Smith & nephew plc
2
Solid biosciences inc.
2
Stryker corporation
4
Takeda pharmaceutical company limited
6
Terumo corp
2
Teva pharmaceutical industries ltd
3
Tg therapeutics, inc.
2
Therapeuticsmd, inc.
3
Thermo fisher scientific inc
2
Vaxart, inc.
3
Vertex pharmaceuticals incorporated
2
Symbols
AAPL
45
ABB
62
ABBNY
32
ABBV
37
ABLZF
49
ABT
80
ACAQ
51
AEM
40
AMGN
47
ARVL
157
AUY
33
BDX
37
CLLS
37
CNS
47
CNXC
36
DELL
31
DHR
40
DOV
37
ENB
32
ERIC
36
EXPR
31
FNCTF
303
FRBA
44
FST
41
GE
37
GIC
31
GLAXF
35
GOOG
51
GOOGL
51
GSK
49
HON
63
HUBS
58
JNJ
167
LLY
70
LMNR
39
LTUM
47
MDT
46
MFC
64
MMM
38
MS
302
NBR
34
NDAQ
50
NVDA
37
NVS
56
NVSEF
44
OOMA
68
ORCL
32
PPRUF
41
PPRUY
41
SAP
45
SLG
39
SNOW
52
SNY
161
SNYNF
132
SRE
34
TMO
67
VSAC
46
WPM
38
WSFS
48
XYF
60
Exchanges
Amex
3
Nasdaq
91
Nyse
167
Crawled Date
2023 - 12 - 12
2
2023 - 11 - 28
2
2023 - 09 - 22
2
2023 - 08 - 10
3
2023 - 07 - 21
2
2023 - 06 - 23
3
2023 - 05 - 16
2
2023 - 03 - 29
2
2023 - 01 - 24
9
2023 - 01 - 19
2
2022 - 02 - 28
1
2022 - 02 - 22
1
2022 - 02 - 18
1
2022 - 02 - 15
1
2022 - 02 - 09
1
2022 - 01 - 14
2
2021 - 11 - 17
1
2021 - 11 - 11
1
2021 - 11 - 09
2
2021 - 10 - 29
1
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 25
2
2021 - 10 - 20
1
2021 - 10 - 19
1
2021 - 10 - 15
3
2021 - 10 - 14
2
2021 - 10 - 07
1
2021 - 10 - 04
1
2021 - 09 - 21
1
2021 - 09 - 17
1
2021 - 09 - 16
2
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 09 - 01
1
2021 - 08 - 31
1
2021 - 08 - 25
2
2021 - 08 - 24
1
2021 - 08 - 19
1
2021 - 08 - 17
2
2021 - 08 - 05
2
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 30
2
2021 - 07 - 26
1
2021 - 07 - 23
1
2021 - 07 - 19
1
2021 - 07 - 02
1
2021 - 06 - 23
2
2021 - 06 - 15
1
2021 - 06 - 09
1
2021 - 05 - 21
1
2021 - 05 - 19
2
2021 - 05 - 12
1
2021 - 04 - 20
2
2021 - 04 - 12
1
2021 - 04 - 06
1
2021 - 03 - 19
2
2021 - 03 - 16
2
2021 - 03 - 04
1
Crawled Time
00:00
85
00:11
1
00:20
33
01:00
66
01:08
1
02:00
39
03:00
30
04:00
15
04:08
1
04:09
1
04:20
9
05:00
45
06:00
81
06:03
1
07:00
69
08:00
64
08:20
5
09:00
95
09:03
1
10:00
97
10:10
1
10:37
1
10:41
1
11:00
200
11:01
3
11:33
1
12:00
351
12:01
1
12:07
1
12:10
1
12:15
31
12:20
78
12:30
61
13:00
268
13:02
1
13:04
1
13:15
43
13:20
61
13:30
80
14:00
297
14:01
2
14:15
40
14:20
64
14:30
92
14:49
2
15:00
305
15:15
55
15:20
51
15:30
100
16:00
269
16:01
2
16:20
26
17:00
311
18:00
214
19:00
165
20:00
182
20:20
17
21:00
176
22:00
167
23:00
120
Source
ir.pulmatrix.com
1
spacfeed.com
8
www.acadiahealthcare.com
1
www.biospace.com
36
www.empowerclinics.com
1
www.fda.gov
1
www.globenewswire.com
12
www.interpublic.com
1
www.intricon.com
1
www.nanthealth.com
1
www.prnewswire.com
103
www.thehackettgroup.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Jnj
crawled time :
22:00
save search
Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
0.53%
|
O:
0.89%
H:
0.0%
C:
0.0%
macular
growth
market
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published:
2024-04-11
(Crawled : 22:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-5.8%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-7.39%
|
O:
-8.65%
H:
3.19%
C:
1.6%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-1.05%
|
O:
-1.65%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.72%
|
O:
-0.0%
H:
0.52%
C:
-1.04%
growth
market
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Published:
2024-04-10
(Crawled : 22:00)
- biospace.com/
RLYB
|
News
|
$1.84
3.96%
3.8%
240K
|
|
7.27%
|
O:
-3.03%
H:
4.38%
C:
1.87%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-1.47%
|
O:
0.21%
H:
0.0%
C:
0.0%
risk
solutions
for
collaboration
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published:
2024-04-08
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-1.77%
|
O:
-0.3%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.91%
|
O:
0.05%
H:
0.02%
C:
-2.62%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
-0.99%
|
O:
0.06%
H:
0.22%
C:
0.0%
KNSA
|
$17.66
3.31%
3.2%
610K
|
Health Technology
|
-3.34%
|
O:
0.23%
H:
1.58%
C:
0.06%
IMAB
|
$1.81
0.56%
0.55%
200K
|
Health Technology
|
-0.55%
|
O:
-0.55%
H:
1.39%
C:
0.0%
GLPG
|
News
|
$29.47
1.38%
1.36%
120K
|
Health Technology
|
-8.76%
|
O:
0.0%
H:
0.39%
C:
-0.66%
positive
growth
market
Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight
Published:
2024-04-04
(Crawled : 22:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-9.92%
|
O:
-0.52%
H:
0.71%
C:
0.71%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.04%
|
O:
-1.84%
H:
0.0%
C:
0.0%
SLDB
|
$9.08
0.44%
0.44%
300K
|
Health Technology
|
-26.98%
|
O:
-0.73%
H:
1.3%
C:
-1.06%
growth
market
Biden, Sanders Target Drug Prices at White House Event
Published:
2024-04-03
(Crawled : 22:00)
- biospace.com/
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.46%
|
O:
0.02%
H:
0.0%
C:
0.0%
drug
house
Retinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsight
Published:
2024-04-02
(Crawled : 22:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-11.68%
|
O:
-0.65%
H:
2.43%
C:
-0.28%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.46%
|
O:
0.02%
H:
0.0%
C:
0.0%
market
Diabetic Kidney Disease Market to Witness Upsurge in Growth at a CAGR of ~6.5% by 2034 | DelveInsight
Published:
2024-04-01
(Crawled : 22:00)
- prnewswire.com
PKX
|
News
|
$71.48
-0.17%
0.0%
89K
|
Non-Energy Minerals
|
-7.05%
|
O:
-0.77%
H:
0.0%
C:
-0.85%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.49%
|
O:
-0.77%
H:
0.8%
C:
0.74%
disease
kidney
growth
market
diabetic
Titan Medical Reports Fiscal Year 2023 Results
Published:
2024-03-29
(Crawled : 22:00)
- globenewswire.com
TMDI
|
News
|
$0.14
-26.32%
-35.52%
0
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
year
medical
results
Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
Published:
2024-03-21
(Crawled : 22:00)
- biospace.com/
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.15%
|
O:
-0.03%
H:
0.0%
C:
0.0%
business
year
financial
results
Oral Care Market Size, Share & Trends Analysis Report 2024-2030: Toothpaste & Toothbrush Segments Lead with Rapid Innovation
Published:
2024-03-14
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.26%
|
O:
-1.58%
H:
0.0%
C:
0.0%
CL
|
$88.58
0.28%
0.0%
4M
|
Consumer Non-Durables
|
-0.02%
|
O:
-1.01%
H:
1.51%
C:
1.13%
report
rapid
innovation
care
trends
market
Biopharma Layoff Tracker 2024: Perrigo, Denali, Galapagos and More Cut Staff
Published:
2024-02-28
(Crawled : 22:00)
- biospace.com/
RLYB
|
News
|
$1.84
3.96%
3.8%
240K
|
|
-16.51%
|
O:
0.94%
H:
10.98%
C:
3.74%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.81%
|
O:
0.67%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.7422
-2.66%
-2.74%
1.5M
|
Health Technology
|
-40.16%
|
O:
5.51%
H:
0.0%
C:
-3.36%
TXMD
|
News
|
$1.875
-0.27%
-0.27%
21K
|
Health Technology
|
-20.0%
|
O:
0.0%
H:
1.7%
C:
0.85%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.29%
|
O:
-0.63%
H:
0.0%
C:
0.0%
PTCT
|
News
S
|
$25.38
-2.27%
-2.32%
750K
|
Health Technology
|
-8.27%
|
O:
-0.46%
H:
2.61%
C:
0.07%
NKTR
|
News
|
$1.415
4.04%
3.89%
1.1M
|
Health Technology
|
81.33%
|
O:
2.67%
H:
1.3%
C:
-6.49%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
1.7%
|
O:
-0.45%
H:
0.34%
C:
-0.06%
GLPG
|
News
|
$29.47
1.38%
1.36%
120K
|
Health Technology
|
-20.88%
|
O:
-0.11%
H:
0.25%
C:
-1.69%
AMRN
|
News
|
$0.8827
1.96%
1.93%
760K
|
Health Technology
|
-35.56%
|
O:
-0.74%
H:
0.0%
C:
-1.49%
GOOGL
|
News
S
|
$158.17
1.21%
1.19%
21M
|
Technology Services
|
12.53%
|
O:
-0.71%
H:
0.08%
C:
-1.1%
GOOG
|
News
4
|
$159.82
1.18%
1.17%
16M
|
Technology Services
|
12.74%
|
O:
-0.71%
H:
0.13%
C:
-1.2%
OCX
|
News
|
$2.5
-0.4%
-0.4%
23K
|
Health Technology
|
-15.2%
|
O:
0.36%
H:
2.97%
C:
-0.36%
biopharma
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
Published:
2024-02-23
(Crawled : 22:00)
- biospace.com/
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.06%
|
O:
0.28%
H:
0.0%
C:
0.0%
LEGN
|
News
|
$47.42
0.77%
0.76%
1.8M
|
Health Technology
|
-23.75%
|
O:
2.07%
H:
5.02%
C:
4.92%
carvykti
chmp
biotech
positive
treatment
therapy
Biopharma Layoff Tracker 2024: Ring, Kenvue, Sonata and More Cut Staff
Published:
2024-02-20
(Crawled : 22:00)
- biospace.com/
RLYB
|
News
|
$1.84
3.96%
3.8%
240K
|
|
-11.5%
|
O:
1.5%
H:
0.99%
C:
-9.85%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.78%
|
O:
0.12%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.7422
-2.66%
-2.74%
1.5M
|
Health Technology
|
-36.4%
|
O:
-2.09%
H:
6.84%
C:
5.13%
TXMD
|
News
|
$1.875
-0.27%
-0.27%
21K
|
Health Technology
|
-16.81%
|
O:
0.0%
H:
0.89%
C:
0.44%
PTCT
|
News
S
|
$25.38
-2.27%
-2.32%
750K
|
Health Technology
|
0.23%
|
O:
-0.77%
H:
2.53%
C:
1.05%
NKTR
|
News
|
$1.415
4.04%
3.89%
1.1M
|
Health Technology
|
91.04%
|
O:
2.54%
H:
0.0%
C:
-9.1%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
2.8%
|
O:
1.09%
H:
0.57%
C:
-0.45%
AMRN
|
News
|
$0.8827
1.96%
1.93%
760K
|
Health Technology
|
-28.1%
|
O:
-2.48%
H:
2.54%
C:
0.85%
GOOGL
|
News
S
|
$158.17
1.21%
1.19%
21M
|
Technology Services
|
11.22%
|
O:
-0.62%
H:
1.74%
C:
1.05%
GOOG
|
News
4
|
$159.82
1.18%
1.17%
16M
|
Technology Services
|
11.42%
|
O:
-0.58%
H:
1.69%
C:
0.89%
OCX
|
News
|
$2.5
-0.4%
-0.4%
23K
|
Health Technology
|
-16.33%
|
O:
-0.67%
H:
3.02%
C:
3.02%
biopharma
Biopharma Layoff Tracker 2024: Kenvue, Sonata, Aurinia and More Cut Staff
Published:
2024-02-16
(Crawled : 22:00)
- biospace.com/
RLYB
|
News
|
$1.84
3.96%
3.8%
240K
|
|
-4.84%
|
O:
0.0%
H:
11.29%
C:
7.53%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.57%
|
O:
-0.83%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.7422
-2.66%
-2.74%
1.5M
|
Health Technology
|
-35.59%
|
O:
-0.85%
H:
5.98%
C:
2.14%
TXMD
|
News
|
$1.875
-0.27%
-0.27%
21K
|
Health Technology
|
-16.07%
|
O:
1.79%
H:
0.0%
C:
-0.88%
PTCT
|
News
S
|
$25.38
-2.27%
-2.32%
750K
|
Health Technology
|
1.09%
|
O:
-1.05%
H:
3.66%
C:
1.93%
NKTR
|
News
|
$1.415
4.04%
3.89%
1.1M
|
Health Technology
|
83.78%
|
O:
-2.7%
H:
1.94%
C:
-1.13%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
2.74%
|
O:
0.43%
H:
0.2%
C:
-0.48%
AMRN
|
News
|
$0.8827
1.96%
1.93%
760K
|
Health Technology
|
-28.69%
|
O:
0.0%
H:
0.82%
C:
-0.82%
GOOGL
|
News
S
|
$158.17
1.21%
1.19%
21M
|
Technology Services
|
9.46%
|
O:
0.15%
H:
0.14%
C:
-1.73%
GOOG
|
News
4
|
$159.82
1.18%
1.17%
16M
|
Technology Services
|
9.73%
|
O:
0.19%
H:
0.19%
C:
-1.7%
OCX
|
News
|
$2.5
-0.4%
-0.4%
23K
|
Health Technology
|
-12.54%
|
O:
2.79%
H:
1.69%
C:
1.69%
biopharma
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
Published:
2024-02-12
(Crawled : 22:00)
- globenewswire.com
CNTB
|
$1.4
3.7%
3.57%
73K
|
Professional, Scientific, and T...
|
5.88%
|
O:
-1.18%
H:
5.56%
C:
-2.78%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.78%
|
O:
0.7%
H:
0.0%
C:
0.0%
biopharma
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
Published:
2024-02-07
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.64%
|
O:
-0.63%
H:
0.0%
C:
0.0%
PTGX
S
|
$26.82
0.79%
0.78%
340K
|
Health Technology
|
4.72%
|
O:
-0.04%
H:
4.09%
C:
2.8%
jnj-2113
psoriasis
positive
results
study
Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen
Published:
2024-01-25
(Crawled : 22:00)
- prnewswire.com
ACLX
|
$54.43
4.67%
4.46%
410K
|
|
-12.37%
|
O:
0.2%
H:
5.99%
C:
5.65%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.27%
|
O:
0.8%
H:
0.0%
C:
0.0%
MTEM
|
$1.555
3.67%
3.54%
23K
|
Health Technology
|
-59.89%
|
O:
-2.94%
H:
3.03%
C:
3.03%
IONS
|
$41.85
1.9%
1.86%
630K
|
Health Technology
|
-20.38%
|
O:
0.43%
H:
0.27%
C:
-0.6%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-14.77%
|
O:
0.66%
H:
0.64%
C:
-1.11%
IMAB
|
$1.81
0.56%
0.55%
200K
|
Health Technology
|
-0.55%
|
O:
1.1%
H:
0.27%
C:
-1.64%
companies
growth
market
Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published:
2024-01-17
(Crawled : 22:00)
- prnewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
17.42%
|
O:
-0.36%
H:
1.32%
C:
1.18%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.96%
|
O:
-0.21%
H:
0.0%
C:
0.0%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-8.34%
|
O:
-0.5%
H:
0.76%
C:
0.32%
EDIT
|
News
|
$5.465
-2.41%
-2.47%
1.6M
|
Health Technology
|
-33.41%
|
O:
0.83%
H:
0.35%
C:
-3.66%
AGIO
|
$31.82
5.33%
5.06%
1.2M
|
Health Technology
|
39.15%
|
O:
0.41%
H:
0.0%
C:
-2.2%
crispr
companies
therapeutics
growth
study
market
Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
Published:
2024-01-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.91%
|
O:
-1.02%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.25%
|
O:
0.77%
H:
0.17%
C:
-1.65%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
IMAB
|
$1.81
0.56%
0.55%
200K
|
Health Technology
|
-3.23%
|
O:
-1.08%
H:
0.0%
C:
-8.42%
resolve
key
growth
study
market
← Previous
1
2
3
4
5
6
7
8
9
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.